These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24753957)

  • 1. Incessant ovulation and ovarian cancer - a hypothesis re-visited.
    Fathalla MF
    Facts Views Vis Obgyn; 2013; 5(4):292-7. PubMed ID: 24753957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-hormonal interruption of incessant ovulation as a potential approach for ovarian cancer prevention.
    Fathalla MF
    Int J Gynaecol Obstet; 2016 Mar; 132(3):356-8. PubMed ID: 26876699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What are the mechanisms of action of the different contraceptive methods to reduce the risk of ovarian cancer?
    Sánchez-Borrego R; Sánchez-Prieto M
    Eur J Contracept Reprod Health Care; 2021 Feb; 26(1):79-84. PubMed ID: 33245019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
    Elomaa K; Rolland R; Brosens I; Moorrees M; Deprest J; Tuominen J; Lähteenmäki P
    Am J Obstet Gynecol; 1998 Jul; 179(1):41-6. PubMed ID: 9704763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral contraception and its beneficial gynecological effects].
    Belaisch J; Hommais-loufrani B
    Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for epithelial ovarian tumours of borderline malignancy.
    Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C
    Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence.
    Riman T; Persson I; Nilsson S
    Clin Endocrinol (Oxf); 1998 Dec; 49(6):695-707. PubMed ID: 10209555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian follicles during oral contraceptive cycles: their potential for ovulation.
    Killick SR
    Fertil Steril; 1989 Oct; 52(4):580-2. PubMed ID: 2680616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis.
    Smith SK; Kirkman RJ; Arce BB; McNeilly AS; Loudon NB; Baird DT
    Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic salpingectomy for the prevention of ovarian cancer: Who should we target?
    Kotsopoulos J; Narod SA
    Int J Cancer; 2020 Sep; 147(5):1245-1251. PubMed ID: 32037528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective on ovarian cancer: why prevent?
    Hoskins WJ
    J Cell Biochem Suppl; 1995; 23():189-99. PubMed ID: 8747396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Incessant ovulation" and ovarian cancer.
    Casagrande JT; Louie EW; Pike MC; Roy S; Ross RK; Henderson BE
    Lancet; 1979 Jul; 2(8135):170-3. PubMed ID: 89281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights regarding pharmacologic approaches for ovarian cancer prevention.
    Rodriguez G
    Hematol Oncol Clin North Am; 2003 Aug; 17(4):1007-20, x. PubMed ID: 12959189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncontraceptive health benefits of oral steroidal contraceptives.
    Mishell DR
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):809-16. PubMed ID: 7065059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Events of reproductive life and the incidence of epithelial ovarian cancer.
    Risch HA; Weiss NS; Lyon JL; Daling JR; Liff JM
    Am J Epidemiol; 1983 Feb; 117(2):128-39. PubMed ID: 6681935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptive pills. Prevention of ovarian cancer and other benefits.
    Berchuck A; Schildkraut J
    N C Med J; 1997; 58(6):404-7; discussion 408. PubMed ID: 9392951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact and mechanistic role of oral contraceptive pills on the number and epithelial type of ovarian cortical inclusion cysts; a clinicopathology and immunohistochemical study.
    DastranjTabrizi A; MostafaGharabaghi P; SheikhzadehHesari F; Sadeghi L; Zamanvandi S; Sarbakhsh P; Ghojazadeh M
    Diagn Pathol; 2016 Mar; 11():30. PubMed ID: 27000861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects on ovarian activity of ulipristal acetate when 'quickstarting' a combined oral contraceptive pill: a prospective, randomized, double-blind parallel-arm, placebo-controlled study.
    Cameron ST; Berger C; Michie L; Klipping C; Gemzell-Danielsson K
    Hum Reprod; 2015 Jul; 30(7):1566-72. PubMed ID: 25994664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian epithelial dysplasia in relation to ovulation induction and nulliparity.
    Nieto JJ; Crow J; Sundaresan M; Constantinovici N; Perrett CW; MacLean AB; Hardiman PJ
    Gynecol Oncol; 2001 Aug; 82(2):344-9. PubMed ID: 11531291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why do inadvertent pregnancies occur in oral contraceptive users? Effectiveness of oral contraceptive regimens and interfering factors.
    Fraser IS; Jansen RP
    Contraception; 1983 Jun; 27(6):531-51. PubMed ID: 6413129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.